INTRODUCTION
Food legumes are valuable sources of dietary proteins, carbohydrates, fibres, minerals, vitamins and play important, diverse role in the human nutrition and animal feeding. They contain a number of bioactive compounds that are not nutrients, but exert metabolic effects on human and animal health. These compounds have long been classified as antinutritional factors, but recent studies have reconsidered their impact on health and demonstrated that these antinutritional compounds, like lectins and protease inhibitors may have beneficial properties also. These aspects have received increased attention in the areas of food science and nutrition and have been associated with beneficial health-promoting properties, like managing high cholesterol and type-2 diabetes and in the prevention of cancer. The modern biotechnology also exploits these compounds in the plant defence strategies.
Common beans (Phaseolus vulgaris) contain bioactive alpha-amylase inhibitors (αΑI), which reduce amylase activity and starch digestion. The group αΑI-1 has been shown to inhibit human and insect derived pancreatic and salivary alpha-amylases. The αAI-1 is derived from a pre-protein, of which the native or unprocessed molecular weight has been estimated to be around 28 kDa. It is synthesized on the endo-plasmic reticulum and after the cleavage of the signal peptide, glycans are added in the Golgi apparatus which leads to an increase in the molecular weight of the pre-protein to 32-36 kDa. Finally the pre-protein is transported to protein storage vacuoles, where proteolytic cleavage results into two subunits (α-and β-chains) of the inhibitor.
More recently, common bean derived alpha-amylase inhibitor-1 (αΑI-1) has been tested in clinical studies for its application in weight loss and glycemic control as they delay carbohydrate absorption. However, clinical studies have shown that crude preparation of bean αΑI-1 had no inhibitor-activity effect, while a partially purified bean product was found to indicate body weight loss and reduce spikes in blood sugar due to its αΑI-1 activity. Up to now there is not enough experimental data to understand why a less purified preparation of αAI-1 can be more effective physiologically. To understand the mechanism of this action requires further researches.
As the αΑI-1s play an important role in the starch digestion of animals, plants and microorganisms, the modern biotechnology has utilized this property in the plant protection against insects. The introduction of the bean (Phaseolus vulgaris) αAI-1gene in pea (Pisum sativum) leads to expression of seed-specific αAI-1 protein accumulated at high level and undergoes post-translational modification. This proved to be a good strategy for protection of the plant from damage by pea weevil (Bruchus pisorum) under greenhouse and field growth conditions as well. However, a study demonstrated that the αAI-1expressing pea led to the synthesis of a modified form of the protein with altered immunogenicity. This modification was thought to be responsible for the reported allergenicity in mice of the transgenic pea but not the bean. The authors presumed that the differences are due to post-translational modifications. Further investigations revealed some heterogeneous structural variations in genetically modified pea and bean due to differences in glycans, but no evidence was found for the increased immunogenicity of the αAI-1 in pea. The αAI-1s from the two sources can induce similar immune responses, both αAI-1 forms elicited Th1 and Th2 antibody responses, suggesting that both forms can be immunogenic. Therefore the allergenic effect of the αAI-1 is still controversial.
Most of the proteins are hydrolyzed in the gastrointestinal tract, but some bioactive proteins can show resistance against the digestive enzymes. There are informations about the effects of bean αΑI-1 on the digestion, but experimental data are missing so far on the digestive fate of bean αΑI-1. Many studies oriented to the assessing of structure-function relationship of the αΑI-1, but further accumulation of the data is still required for the better understanding, especially the variability assessment of the bean αAIs and its transgenic expression. The proteomics investigation of the protein is reasonable for nutrition and food safety aspects. -Investigate the IgE-reactivity of the Tendergreen bean and the GM pea αAI-1s using sera obtained from severe combined immunodeficient mouse model in comparison with clinically proved legume allergic human sera.
AIMS -Characterize αAI-1s obtained from Hungarian
-Describe the difference in the digestive fate of common bean αAI-1 released from the purified protein and the crude protein extracts using simulated gastric fluid and acute rat digestion model.
MATERIALS AND METHODS

Common beans and isolated proteins
Reference materials (Bean and pea meals and isolates provided by the Australian CSIRO (Higgins T.J.W.) institute in the framework of EU FP7 GMSAFOOD project):
-Donor Tendergreen bean meal (Phaseolus vulgaris L. vs Tendergreen, TG) and purified αAI-1 (MARSHALL and LAUDA, 1975) in lyophilised form -Genetically modified (GM) pea meal (Pisum sativum L.), which is a product of an Agrobacterium-mediated transformation (SCHROEDER et al.,1995) containing a chimera αAI-1 gene (SHADE et al. (1994) and purified αAI-1 (MARSHALL and LAUDA, 1975) in lyophilised form 
Methods
-Meal of the Hungarian beans and GM pea were ground to a fine powder, stirred with distilled water in 1:10 ratio (w/v) for 1 h at room temperature and centrifuged at 10000 g for 10 minutes.
-The electrophoresis separations in denaturation conditions (SDS-PAGE) were carried out by the method of LAEMMLI (1970) using 15% separation gel and 6% stacking gel at 200 V, 400 mA in MINI-PROTEAN 3-CELL (Bio-Rad) equipment. The gels were fixed in 20% TCA (trichloracetic acid) and stained with Commassie Brilliant Blue R-250.
-For native-PAGE 10 % gel was used at 200 V, 47 mA. After separation the gels were incubated in alpha-amylase enzyme and starch containing buffers in room temperature.
The active αAI bands were visualized by potassium iodide solution.
-The first dimension of the two-dimensional electrophoresis (2-DE) was the isoelectric focusing, which was carried out by linearly increasing voltage from 250V to 24.000 Vh using a commercial IPG strip, 7 cm long and with a pH range of 3-10. The strips were incubated in DTT and iodoacetamide containing equilibrating solution for 15 min at room temperature with gentle shaking. The second dimension was carried out on 15% SDS-PAGE with 1 h run at 200 V in a BioRad Protean appliance.
-The lab-on-a-chip (LOC) electrophoresis was carried out by the instructions of the manufacturer.
-The separated αAI proteins were transferred onto a 0.45µm PVDF membrane for 1. methanol.
-The deglycosylation of proteins were carried out by the method of WOODWARD (1984) , where the carbohydrates were eliminate from the protein chains by sodium-metaperiodate in acidic conditions.
-The Schiff-staining was carried out by the method of SACCHARIUS (1969). The proteins were incubated in periodic acid, Schiff-reagent and metabisulfite.
-For protein purification DEAE-anion-exchange and Superose 12 gel-filtration columns were used.
-The αAI activity was determined by the method of MURAO (1981) , where the protein solution was incubated with porcine pancreatic alpha-amylase enzyme and starch. The reaction was stopped by acidic solution and incubated in iodide solution. The absorbance was measured at 660 nm, from which the activity was determined by the following:
Inhibitory activity (%) = OD sample -OD control / OD blind -OD control x 100 -The haemagglutination activity was determined by the modified method of CUADRADO (1996) . Protein extracts were prepared from the bean and pea meals in 0,9% NaCl solution.
From the extracts 100 µl was pipetted onto the microtiter plate and 100 µl of rat blood containing EDTA were added to the samples. After incubation at room temperature the samples were correlated to control (bean PHA-L) visually. The Tendergreen bean and GM pea derived αAI were used in the same way in 1 mg/ml concentration.
-For mass-spectrometry, the 2-DE separated αAI spots were excise from the gels and digested by trypsin. The digested samples were injected (2 µL) on a Ultimate 3000 RSLC (Dionex, Germany) equipped with a Zorbax 300 SB-C8 column (3. -To monitor the αAI during the gastrointestinal digestion in vivo acute rat model was used.
Followed 60 min digestion the stomach and small intestinal contents were removed.
Proteins were extracted from the lyophilised stomach and small intestinal content and immunreactivity against Tendergreen bean αAI was determined by immunblot and inhibitory activity was determined by native-PAGE. The proteins extracted from the stomach samples were analysed by LOC separation as well.
RESULTS
-According to the first objective, my results obtained by proteomics contributed to the understanding of biochemical properties of αAIs found in Hungarian common bean varieties. Differences were observed in the presence of α-and β-chain peptides in the different αAIs using LC-TOF-MS method. As the detection based on the tryptic digested peptide markers of the Tendergreen bean αAI, therefore carrying-on the work it is need to determine the amino acid sequences of the Hungarian bean derived αAIs as well.
-In the SDS-PAGE separated Hungarian common bean proteins and the GM pea proteins αAI bands were identified by anti αAI polyclonal antibody produced in rabbit. The separated bean and pea proteins showed inhibitory activity as well on native -PAGE, which was proved also by spectrophotometric method.
-While on 2-DE protein map the nGM pea meal contained 54 protein spots, the GM pea meal contained 79 protein spots.
-The bean and pea protein extracts lost the majority of their inhibitory activity after 10 min heat-treatment on 80 C and after 10 min on 100C this activity was totally lost.
-The purified αAIs did not showed hemagglutination activity, contrary to the bean and pea protein extracts.
-Cinc-hydroxide adsorbent based new chromatographic method was developed for αAI purification, by which αAIs were isolated from the Hungarian bean varieties and the GM pea.
-I confirmed that the common bean derived αAIs contain the pre-protein of the αAI contrary to the GM pea derived isolates by electrophoretic (1-DE, 2-DE, LOC) and massspectrometric (LC-ESI-TOF-MS) methods.
-I verified that the αAI-s are glycoproteins by Schiff-staining.
-I detected three protein spots of the αAI's obtained from the P. vulgaris varieties and two spots of the GM pea αAI by 2-DE.
-According to the second objective, I carried out immunblot methods for the assessment of the potential allergencity of the αΑI.
-On the basis of the amino acid sequence of the common bean αΑI using FAO/WHO criteria containing database (SDAP, ADSF, ProAP) I screened known allergens showing sequence homology to the αAI.
-Using epitope prediction software (IEDB) I mapped potential linear B-cell epitopes on the amino acid sequence of the αΑI.
-Using clinically proved legume allergic anonym human sera I selected αAI specific IgE reactive sera by immunblot, which confirmed the potential allergenic property of the bean derived αAI. By deglycosylation of the protein I excluded the carbohydrate-specific IgE binding.
-I found similar IgE recognition patterns of the sera obtained from human patients and sera obtained from HuSCID (humanised severe combined immunodeficient mice) model proved by the GMSAFOOD partners.
-According to the third objective, using simulated gastric fluid, I showed immunreactive αΑI bands after 60 min in vitro pepsin digestion, but the inhibitory activity was not detectable in contraty to the raw bean protein extract, which was still active after the digestion process.
-Using acute rat digestion model I had similar observations. The protein survived the passage through the stomach in inhibitory active form and it was able to form an enzymeinhibitor complex in the small intestine since its activity was not detectable anymore. Even a heat-treated Pinto bean extract proved to be active against the amylase-enzyme in the gastrointestinal tract.
